48 results on '"Kavakli, K."'
Search Results
2. Outcome measures in European patients with haemophilia: Survey of implementation in routine clinical practice, perception of relevance and recommendations by European treaters in the EHTSB
3. Pharmacokinetics of a high-purity plasma-derived factor X concentrate in subjects with moderate or severe hereditary factor X deficiency
4. Efficacy, safety and pharmacokinetics of a new high-purity factor X concentrate in subjects with hereditary factor X deficiency
5. Once-weekly prophylactic treatment vs. on-demand treatment with nonacog alfa in patients with moderately severe to severe haemophilia B
6. Replacement therapy in inherited factor VII deficiency: occurrence of adverse events and relation with surgery
7. Inhibitors to factor VII in congenital factor VII deficiency
8. Health-related quality of life in patients with haemophilia and inhibitors on prophylaxis with anti-inhibitor complex concentrate: results from the Pro-FEIBA study
9. Real-world outcomes with recombinant factor VIIa treatment of acute bleeds in haemophilia patients with inhibitors: results from the international ONE registry
10. Feasibility of using thrombin generation assay (TGA) for monitoring of haemostasis during supplementation therapy in haemophilic patients without inhibitors
11. Pharmacokinetics, safety, and efficacy of a high purity factor X in patients with severe and moderate hereditary factor × deficiency: FP-TU-04.3-2
12. Safety Profiles of Radioisotope Synovectomy in Hemophilia: Izmir Experience for More Than 10 Years: PO-WE-176
13. Radioactive synovectomy of the shoulder joint in patients with hemophilia: PO-WE-155
14. Severe aplastic anemia in a patient with severe hemophilia A: PO-TU-115
15. Acquired hemophilia A and the knowledge/awareness level of Turkish hematology fellows: On behalf of the Turkish Hematology Association, Acquired Hemophilia Working Group: PO-TU-086
16. Study design of 2 randomized, crossover, open-label trials to evaluate the pharmacokinetics, efficacy, and safety of plasma protein-free recombinant factor VIII formulated with sucrose (BAY 81-8973) in previously treated patients with severe hemophilia A: PO-WE-057
17. Enhancing the pharmacokinetic properties of recombinant factor VIII: A first human dose trial with GlycoPEGylated recombinant factor VIII in patients with hemophilia A: FP-MO-03.2-2
18. Efficacy of FEIBA for acute bleeding and surgical haemostasis in haemophilia A patients with inhibitors: a multicentre registry in Turkey
19. A single centre experience in circumcision of haemophilia patients: Izmir protocol
20. Surgery in patients with haemophilia and high responding inhibitors: Izmir experience
21. Presence of a common haplotype in the Turkish VWD patients: 35P03
22. Session S2.4: A single center experience in circumcision of hemophilia patients: Izmir Protocol: 26FP03
23. Session Pre-Congress-Nurses Nursing educational activities in hemophilia summer school: Turkish experience: 23FP03
24. Lupus anticoagulant status in patients with high responder inhibitors: incidence and impact on bleeding tendency: 17P42
25. New data from the ONE Registry: 10P09
26. A prospective, randomized, and crossover study of an activated prothrombin complex concentrate for secondary prophylaxis in patients with hemophilia A and inhibitors (Pro-FEIBA): subject demographics and safety data: 07P13
27. Successful major and minor surgery in patients with hemophilia and high titer inhibitor: 06P11
28. Long-term evaluation of chromosomal breakages after radioisotope synovectomy for treatment of target joints in patients with haemophilia
29. The value of early treatment in patients with haemophilia and inhibitors
30. Radioisotope synovectomy with rhenium186 in haemophilic synovitis for elbows, ankles and shoulders
31. Low-dose immune tolerance induction for paediatric haemophilia patients with factor VIII inhibitors
32. Spinal epidural haematoma in a patient with haemophilia B
33. Radioisotope synovectomy in small joints using with Yttrium 90 versus Rhenium 186: Izmir experience: 18 FP 533
34. Plasma-derived factor concentrates and lower inhibitor incidence in Turkish hemophiliacs: IZMIR experience: 14 PO 393
35. Long-term evaluation of radioisotope synovectomy with Yttrium 90 for chronic synovitis in Turkish haemophiliacs: Izmir experience
36. Iliopsoas haemorrhage in patients with haemophilia: results from one centre
37. The effect of clotting factor concentrates on the immune system in HIV-negative haemophilics
38. Circumcision in older children and young adults with haemophilia (the Moslem tradition)
39. Radioactive synovectomy by Yttrium 90 in young Turkish patients with haemophilia
40. Intraleucocyte platelet-activating factor levels in desmopressin-treated patients with haemophilia A and von Willebrand disease
41. Molecular pathology of haemophilia A in Turkish patients: identification of 36 independent mutations
42. The pelvi-femoral incomplete bone bridge in a patient with mild haemophilia
43. Haemophilia clinical care and research needs: Assessing priorities
44. Clinical experience with moroctocog alfa (AF-CC) in younger paediatric patients with severe haemophilia A: Two open-label studies
45. Safety and effectiveness of room temperature stable recombinant factor VIIa in patients with haemophilia A or B and inhibitors: Results of a multinational, prospective, observational study
46. Low‐dose immune tolerance induction for paediatric haemophilia patients with factor VIII inhibitors
47. Safer and much cheaper circumcision using fibrin glue in severe haemophilia
48. Health-related quality of life in patients with haemophilia and inhibitors on prophylaxis with anti-inhibitor complex concentrate: results from the Pro-FEIBA study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.